Myseum, Inc. - Common Stock (MYSE)

From AI-driven cancer breakthroughs and non-opioid pain innovation to 5G mmWave expansion, mining advancements , and AI-powered mobility , emerging growth stocks are igniting fresh investor momentum this week. Making headlines with major catalysts and clinical or commercial milestones that align with today’s biggest market trends in AI, biotech, clean tech, and digital transformation .

Myseum Inc. (NASDAQ: MYSE) traded higher today, reaching an intraday high of $3.00, up $0.15 from Friday’s close, after announcing the granting of a new Israeli patent covering its advanced digital privacy technology. The stock’s rise reflects growing investor confidence in the company’s innovative approach to secure social sharing, with a current market capitalization of approximately $11 million and 4.2 million shares outstanding.

In today’s MAGA Stocks Undercard lineup, a select group of small-cap innovators are reshaping the landscapes of social media, biotech, and blockchain technology. These companies—each positioned at the forefront of next-generation disruption—are demonstrating renewed investor confidence and sector-wide momentum heading into Q4.

Roadzen Inc. (NASDAQ: RDZN), a global AI leader in insurance and mobility, announced the completion of a $7 million India financing led by Team India, Quant AMC, Valentis Advisors, and Prime Securities Group , valuing its India unit at $91 million and implying a $2 per share parent valuation — nearly double its current market price .